Last reviewed · How we verify

Disci/Rhus toxicodendron comp.®

Charite University, Berlin, Germany · Phase 3 active Small molecule

A homeopathic combination remedy containing Rhus toxicodendron (poison ivy) and other botanical components designed to modulate immune tolerance and reduce inflammatory responses.

A homeopathic combination remedy containing Rhus toxicodendron (poison ivy) and other botanical components designed to modulate immune tolerance and reduce inflammatory responses. Used for Contact dermatitis and allergic skin reactions, Rheumatoid arthritis and joint inflammation.

At a glance

Generic nameDisci/Rhus toxicodendron comp.®
SponsorCharite University, Berlin, Germany
Drug classHomeopathic combination remedy
ModalitySmall molecule
Therapeutic areaImmunology / Allergy
PhasePhase 3

Mechanism of action

Disci/Rhus toxicodendron comp. is a classical homeopathic preparation that combines Rhus toxicodendron with other ingredients. In homeopathic theory, it is intended to work through immune tolerance mechanisms, potentially desensitizing the immune system to allergens or inflammatory triggers. The mechanism is based on homeopathic principles rather than conventional pharmacology.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: